Brief Report
ASPECT-R—A Tool to Rate the Pragmatic and Explanatory Characteristics of a Clinical Trial Design
by Larry D. Alphs, MD, PhD, and Cynthia A. Bossie, PhD Drs. Alphs and Bossie are with Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA. Innov Clin Neurosci. 2016;13(1–2):15–26. Funding: Financial support provided by Janssen Scientific Affairs, LLC. Financial Disclosures: Drs. Alphs and Bossie are full-time employees of Janssen Scientific Affairs, LLC. Key Words: ASPECT-R, […]
Can Baropodometric Analysis be a Useful Tool in the Early Diagnosis of Atypical Parkinsonism? Preliminary Findings
by Anna Furnari, MD; Rocco Salvatore Calabrò, MD, PhD; Donatella Imbesi, MD, PhD; Francesca La Fauci Belponer, PT; David Militi, PhD; Giuseppe Gervasi, PhD; Concetta Pastura MD, PhD; and Placido Bramanti, MD All from IRCCS Centro Neurolesi “Bonino-Pulejo,” Messina, Italy Innov Clin Neurosci. 2014;11(1–2):23–25
Insomnia and Attention Deficit Hyperactivity Disorder in Pediatrics: A Checklist for Parents
by Atmaram Yarlagadda, MD; Megan A. Connell, PsyD; Jayaprada Kasaraneni, MBBS; and Anita H. Clayton, MD Dr. Yarlagadda is Chief, Behavioral Health Services, McDonald Army Health Center in Newport News, Virginia, and Assistant Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia; Dr. Connell is Officer in Charge, Behavioral Health Services, McDonald […]
The Mysterious Illness of Dyce Sombre
by Ronald Pies, MD; Michael H. Fisher, PhD; and C.V. Haldipur, MD, MRCPsy Dr. Pies is from SUNY Upstate Medical University, Syracuse, New York, and Tufts University School of Medicine, Boston, Massachusetts; Dr. Fisher is from Oberlin College, Oberlin, Ohio; and Dr. Halidipur is from SUNY Upstate Medical University, Syracuse, New York. Innov Clin Neurosci. […]
Trends in Combination Antipsychotic Use Among Persons With Commercial Insurance: A Data Snapshot
by Leslie Citrome, MD, MPH; Zhenchao Guo, PhD; Iftekhar Kalsekar, PhD; Robert A. Forbes, PhD; and Tony Hebden, PhD Dr. Citrome is with the Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York; Drs. Kalsekar, Guo, and Hebden are with Bristol-Myers Squibb, Plainsboro, New Jersey Dr. Forbes is with Otsuka Pharmaceutical […]
OPSOCLONUS MYOCLONUS
by Jonathan R. Scarff, MD; Bushra Iftikhar, MD; Aniket Tatugade, MD; Jaekyoung Choi, MD; and Steven Lippmann, MD All from University of Louisville School of Medicine, Department of Psychiatry and Behavioral Sciences, Louisville, Kentucky Innov Clin Neurosci. 2011;8(12):29–31
Anti-N-methyl-D-aspartate Receptor Encephalitis
by Adil Tumbi, MD, MPH; Amin Gilani, MD; Jonathan R. Scarff, MD; Gagandeep Kaur, MD; and Steven Lippmann, MD All from University of Louisville School of Medicine, Psychiatry Department, Louisville, Kentucky Innov Clin Neurosci. 2011;8(9):24–25
Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder
by Scott H. Kollins, PhD; Sharon Youcha, MD; Robert Lasser, MD, MBA; and Michael E. Thase, MD Dr. Kollins is from Duke ADHD Program, Duke University Medical Center, Durham, North Carolina; Drs. Youcha and Lasser are from Shire Development Inc., Wayne, Pennsylvania; and Dr. Thase is from the Department of Psychiatry, University of Pennsylvania School […]
Mental Healthcare Utilization and Sleep Disturbance: A Pilot Study
by Randy A. Sansone, MD; Howard C. Edwards, MD; and Jeremy S. Forbis, PhD Dr. Sansone is a Professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. Edwards is a resident in […]
A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy
by Robert A. Lasser, MD, MBA; Nina R. Schooler, PhD; Mary Kujawa, MD, PhD; Kathleen Jarboe, PHMCNS-BC; John Docherty, MD; and Peter Weiden, MD Dr. Lasser is with Shire Pharmaceuticals (Dr. Lasser was with Johnson & Johnson at the time of the development of this manuscript); Dr. Schooler is with SUNY Downstate Medical Center, Brooklyn, […]
